Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRB Spruce Biosciences, Inc.

盘前交易 11-22 07:08:20 EST

0.4910

+0.0010

+0.20%

最高0.5039	最低0.4760	成交量18.84万
今开0.4760	昨收0.4900	日振幅5.69%
总市值2,028万	流通市值1,166万	总股本4,130万
成交额9.19万	换手率0.79%	流通股本2,374万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRB","market":"US","secType":"STK","nameCN":"Spruce Biosciences, Inc.","latestPrice":0.491,"timestamp":1732222800000,"preClose":0.49,"halted":0,"volume":188357,"delay":0,"floatShares":23743480,"shares":41302599,"eps":-0.959594,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.001,"latestTime":"11-22 07:08:20 EST","open":0.476,"high":0.5039,"low":0.476,"amount":91916.24578578,"amplitude":0.056939,"askPrice":0.5648,"askSize":100,"bidPrice":0.4386,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.959594,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732285800000},"adr":0,"listingDate":1602216000000,"adjPreClose":0.491,"postHourTrading":{"tag":"盘后","latestPrice":0.48,"preClose":0.491,"latestTime":"18:12 EST","volume":381,"amount":182.8875,"timestamp":1732230744091},"volumeRatio":0.7343839552146236,"impliedVol":1.7522,"impliedVolPercentile":0.6968},"requestUrl":"/m/hq/s/SPRB","defaultTab":"news","newsList":[{"id":"2483309834","title":"Spruce Biosciences, Inc.盘中异动 大幅下挫5.18%报0.494美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483309834?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:59","pubTimestamp":1731686361,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时59分，Spruce Biosciences, Inc.股票出现异动，股价急速下挫5.18%。截至发稿，该股报0.494美元/股，成交量5.698万股，换手率0.14%，振幅3.03%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为3.45%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235922abc512bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235922abc512bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2482367087","title":"斯普鲁斯生物科学公司（Spruce Biosciences Inc）报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482367087","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482367087?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:31","pubTimestamp":1731339095,"startTime":"0","endTime":"0","summary":"斯普鲁斯生物科学公司报告截至 9 月 30 日的季度业绩 - 收益摘要Spruce Biosciences Inc SPRB.OQ报告，截至9月30日的季度调整后每股亏损21美分，高于去年同期的每股-30美分。七位分析师对该季度的平均预期是每股亏损 24 美分。Spruce Biosciences Inc 公布的本季度每股收益为亏损 21 美分。Spruce Biosciences Inc 本季度股价上涨了 12.8%，今年迄今为止亏损了 81.7%。华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4T3MI13K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2482073595","title":"Spruce Biosciences, Inc.盘中异动 早盘大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482073595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482073595?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:49","pubTimestamp":1731336594,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时49分，Spruce Biosciences, Inc.股票出现异动，股价快速下跌5.02%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224954971a5b90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224954971a5b90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2481483289","title":"Spruce Biosciences Inc 预计每股亏损24美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481483289","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481483289?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:53","pubTimestamp":1731081235,"startTime":"0","endTime":"0","summary":"Spruce Biosciences Inc 预计每股亏损24美分 - 财报前瞻斯普鲁斯生物科学公司SPRB.OQ SPRB.O预计将在11月11日公布截至2024年9月30日的业绩报告时显示季度收入下降(估计)。LSEG 分析师对 Spruce Biosciences Inc 的平均预期是每股亏损 24 美分。华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元，高于上一次 0.55 美元的收盘价。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF1TD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB"],"gpt_icon":0},{"id":"2479035353","title":"Spruce Biosciences, Inc.盘中异动 大幅跳水5.37%报0.534美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479035353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479035353?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:04","pubTimestamp":1730383479,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时04分，Spruce Biosciences, Inc.股票出现波动，股价快速下跌5.37%。截至发稿，该股报0.534美元/股，成交量9.5668万股，换手率0.23%，振幅2.48%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.55%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122043998e3fbc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122043998e3fbc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2478480469","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478480469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478480469?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:09","pubTimestamp":1730128140,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时09分，Spruce Biosciences, Inc.股票出现波动，股价快速拉升5.53%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028230900a1f27fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028230900a1f27fc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2478519726","title":"Spruce Biosciences, Inc.盘中异动 快速拉升5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478519726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478519726?lang=zh_cn&edition=full","pubTime":"2024-10-25 00:02","pubTimestamp":1729785767,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日00时02分，Spruce Biosciences, Inc.股票出现波动，股价大幅上涨5.70%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Viking Therapeutics, Inc.、Dbv Technologies涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为262.64%、181.19%、140.90%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为77.83%、71.78%、60.32%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025000247ab70f117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025000247ab70f117&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2477967108","title":"Spruce Biosciences, Inc.盘中异动 快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477967108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477967108?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:50","pubTimestamp":1729529436,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时50分，Spruce Biosciences, Inc.股票出现异动，股价急速拉升5.01%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Genprex, Inc.、Biovie Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为8061.09%、3386.65%、1525.48%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022005036ab6bc4b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022005036ab6bc4b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2475914279","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475914279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475914279?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:11","pubTimestamp":1729091507,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时11分，Spruce Biosciences, Inc.股票出现异动，股价大幅拉升5.05%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623114798e3ccfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623114798e3ccfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2475319797","title":"Spruce Biosciences, Inc.盘中异动 下午盘股价大涨5.09%报0.467美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475319797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475319797?lang=zh_cn&edition=full","pubTime":"2024-10-15 02:33","pubTimestamp":1728930780,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日02时33分，Spruce Biosciences, Inc.股票出现异动，股价快速上涨5.09%。截至发稿，该股报0.467美元/股，成交量17.9316万股，换手率0.43%，振幅7.25%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015023300971a02a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015023300971a02a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2474209500","title":"Spruce Biosciences, Inc.盘中异动 临近收盘快速跳水5.56%报0.425美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474209500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474209500?lang=zh_cn&edition=full","pubTime":"2024-10-10 04:01","pubTimestamp":1728504084,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日04时01分，Spruce Biosciences, Inc.股票出现异动，股价急速下挫5.56%。截至发稿，该股报0.425美元/股，成交量64.3054万股，换手率1.56%，振幅6.02%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101004012498e3b879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101004012498e3b879&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2472644946","title":"Spruce Biosciences, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472644946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472644946?lang=zh_cn&edition=full","pubTime":"2024-10-04 01:31","pubTimestamp":1727976686,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日01时31分，Spruce Biosciences, Inc.股票出现波动，股价急速跳水5.00%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.29%。其相关个股中，Elevai Labs, Inc.、Transcode Therapeutics, Inc.、Verrica制药涨幅较大，Theriva Biologics, Inc.、Aditxt, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为5350.38%、1583.77%、940.03%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为142.28%、59.86%、55.45%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410040131269719e3ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410040131269719e3ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2471893933","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大涨6.46%报0.470美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471893933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471893933?lang=zh_cn&edition=full","pubTime":"2024-09-30 22:03","pubTimestamp":1727705020,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日22时03分，Spruce Biosciences, Inc.股票出现异动，股价急速上涨6.46%。截至发稿，该股报0.470美元/股，成交量32.6094万股，换手率0.79%，振幅4.12%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220340ab6728f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220340ab6728f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2470419442","title":"Spruce Biosciences, Inc.盘中异动 股价大涨5.14%报0.448美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470419442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470419442?lang=zh_cn&edition=full","pubTime":"2024-09-25 00:06","pubTimestamp":1727193963,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日00时06分，Spruce Biosciences, Inc.股票出现波动，股价急速上涨5.14%。截至发稿，该股报0.448美元/股，成交量10.7228万股，换手率0.26%，振幅4.27%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925000603a1dc3c44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925000603a1dc3c44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139"],"gpt_icon":0},{"id":"2459210367","title":"Spruce Biosciences, Inc.盘中异动 早盘急速上涨5.02%报0.462美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459210367","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459210367?lang=zh_cn&edition=full","pubTime":"2024-08-16 21:53","pubTimestamp":1723816422,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日21时53分，Spruce Biosciences, Inc.股票出现波动，股价快速拉升5.02%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Cingulate Inc.、Seelos Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3553.50%、1415.74%、143.89%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Seelos Therapeutics, Inc.、Cingulate Inc.，振幅分别为100.53%、36.81%、35.42%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081621534397198f63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081621534397198f63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2459906472","title":"Spruce Biosciences, Inc.2024财年第二财季实现净利润-9.18百万美元，同比增加28.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459906472","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459906472?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:03","pubTimestamp":1723737823,"startTime":"0","endTime":"0","summary":"8月16日，Spruce Biosciences, Inc.公布财报，公告显示公司2024财年第二财季净利润为-9.18百万美元，同比增加28.39%；其中营业收入为1.61百万美元，同比减少25.81%，每股基本收益为-0.22美元。从资产负债表来看，Spruce Biosciences, Inc.总负债16.35百万美元，其中短期债务1.89百万美元，资产负债比为4.62，流动比率为5.18。机构评级：截至2024年8月16日，当前有4家机构对Spruce Biosciences, Inc.目标价做出预测，其中目标均价为2.50美元，其中最低目标价为2.00美元，最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000350959be73d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000350959be73d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB"],"gpt_icon":0},{"id":"2459040289","title":"Spruce Biosciences, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459040289","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459040289?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:08","pubTimestamp":1723558104,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时08分，Spruce Biosciences, Inc.股票出现异动，股价快速拉升5.00%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813220824aefe9fa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813220824aefe9fa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2459699387","title":"斯普鲁斯生物科学公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459699387","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459699387?lang=zh_cn&edition=full","pubTime":"2024-08-13 08:50","pubTimestamp":1723510201,"startTime":"0","endTime":"0","summary":"   * Spruce Biosciences Inc   报告，截至6月底的季度调整后每股亏损22美分，高于去年同期的每股-32美分。七位分析师对该季度的平均预期是每股亏损 32 美分。华尔街预期为每股-35美分至-29美分。* 收入为 161 万美元，同比下降 25.6%；分析师预期为 150 万美元。* 斯普鲁斯生物科学公司公布的本季度每股收益为亏损22美分。* Spruce Biosciences Inc 本季度股价下跌了 15.5%，今年迄今为止下跌了 85.1%。华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"斯普鲁斯生物科学公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB"],"gpt_icon":0},{"id":"2459693431","title":"Spruce Biosciences, Inc.盘中异动 下午盘股价大跌5.12%报0.415美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459693431","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459693431?lang=zh_cn&edition=full","pubTime":"2024-08-13 01:35","pubTimestamp":1723484124,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日01时35分，Spruce Biosciences, Inc.股票出现波动，股价急速跳水5.12%。截至发稿，该股报0.415美元/股，成交量35.4254万股，换手率0.86%，振幅7.75%。Spruce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Spruce Biosciences, Inc.公司简介：Spruce Biosciences Inc 是一家后期生物制药公司，专注于开发和商业化针对未满足医疗需求的罕见内分泌疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813013525942000ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813013525942000ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRB"],"gpt_icon":0},{"id":"2458180425","title":"Spruce Biosciences Inc    预计每股亏损 32 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458180425","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458180425?lang=zh_cn&edition=full","pubTime":"2024-08-09 23:52","pubTimestamp":1723218745,"startTime":"0","endTime":"0","summary":"* LSEG分析师对Spruce Biosciences Inc的平均预期是每股亏损32美分。* 华尔街对 Spruce Biosciences Inc 的 12 个月目标价中位数为 2.50 美元，高于上一次 0.44 美元的收盘价。8月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Spruce Biosciences Inc    预计每股亏损 32 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sprucebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0576},{"period":"1month","weight":-0.1169},{"period":"3month","weight":0.0285},{"period":"6month","weight":-0.2961},{"period":"1year","weight":-0.639},{"period":"ytd","weight":-0.8324}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spruce Biosciences, Inc.最初于2014年11月在特拉华州成立为一家有限责任公司。该公司是一家处于后期阶段的生物制药公司，专注于开发和商业化治疗罕见的内分泌疾病的新疗法，这些疾病的医疗需求尚未得到满足。该公司正在初步开发全资候选产品tildacerfont，作为潜在的第一个非甾体疗法，为患有典型先天性肾上腺增生症的患者提供显著改善的疾病控制和减少类固醇负担。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.33989},{"month":2,"riseRate":0.5,"avgChangeRate":0.009378},{"month":3,"riseRate":0,"avgChangeRate":-0.297383},{"month":4,"riseRate":0,"avgChangeRate":-0.078867},{"month":5,"riseRate":0.5,"avgChangeRate":-0.003763},{"month":6,"riseRate":0.25,"avgChangeRate":-0.126985},{"month":7,"riseRate":0.5,"avgChangeRate":-0.017508},{"month":8,"riseRate":0.25,"avgChangeRate":-0.021147},{"month":9,"riseRate":0.5,"avgChangeRate":-0.141116},{"month":10,"riseRate":0.25,"avgChangeRate":-0.193698},{"month":11,"riseRate":0.4,"avgChangeRate":-0.001157},{"month":12,"riseRate":0.5,"avgChangeRate":0.416923}],"exchange":"NASDAQ","name":"Spruce Biosciences, Inc.","nameEN":"Spruce Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spruce Biosciences, Inc.,SPRB,Spruce Biosciences, Inc.股票,Spruce Biosciences, Inc.股票老虎,Spruce Biosciences, Inc.股票老虎国际,Spruce Biosciences, Inc.行情,Spruce Biosciences, Inc.股票行情,Spruce Biosciences, Inc.股价,Spruce Biosciences, Inc.股市,Spruce Biosciences, Inc.股票价格,Spruce Biosciences, Inc.股票交易,Spruce Biosciences, Inc.股票购买,Spruce Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spruce Biosciences, Inc.(SPRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spruce Biosciences, Inc.(SPRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}